[1]资鹏鹏,游清徽,徐贤柱,等.中空介孔二氧化硅在生物医学领域中的应用研究进展[J].江西师范大学学报(自然科学版),2021,(01):86-93.[doi:10.16357/j.cnki.issn1000-5862.2021.01.13]
 ZI Pengpeng,YOU Qinghui,XU Xianzhu,et al.The Research Progress in the Application of Hollow Mesoporous Silica in the Field of Biomedicine[J].Journal of Jiangxi Normal University:Natural Science Edition,2021,(01):86-93.[doi:10.16357/j.cnki.issn1000-5862.2021.01.13]
点击复制

中空介孔二氧化硅在生物医学领域中的应用研究进展()
分享到:

《江西师范大学学报》(自然科学版)[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2021年01期
页码:
86-93
栏目:
出版日期:
2021-02-10

文章信息/Info

Title:
The Research Progress in the Application of Hollow Mesoporous Silica in the Field of Biomedicine
文章编号:
1000-5862(2021)01-0086-08
作者:
资鹏鹏游清徽徐贤柱谢 振王曼莹蔡险峰*
江西师范大学生命科学学院,江西省亚热带植物资源保护与利用重点实验室,江西 南昌 330022
Author(s):
ZI PengpengYOU QinghuiXU XianzhuXIE ZhenWANG ManyingCAI Xianfeng*
College of Life Science,Key Laboratory of the Conservation and Sustainable Utilization for Subtropical Plant Resources of Jiangxi Province,Jiangxi Normal University,Nanchang Jiangxi 330022,China
关键词:
中空介孔二氧化硅 药物控释 靶向 生物成像
Keywords:
hollow mesoporous silica drug controlled release targeting bioimaging
分类号:
R 944
DOI:
10.16357/j.cnki.issn1000-5862.2021.01.13
文献标志码:
A
摘要:
中空介孔二氧化硅具有中空腔结构、低密度、大比表面积、良好的生物相容性和稳定性以及表面易修饰等理化特性,在生物医学领域中受到广泛关注.该文主要概括了近年来功能化中空介孔二氧化硅在药物控释、靶向和生物成像中的应用研究进展,同时对目前中空介孔二氧化硅在临床应用中面临的问题进行了分析.
Abstract:
Hollow mesoporous silica has a hollow cavity structure,low density,large specific surface area,good biocompatibility and stability,easy surface modification and other physical and chemical properties,and has attracted wide attention in the biomedical field.The research progress of functionalized hollow mesoporous silica in drug controlled release,targeting and bioimaging applications in recent years is mainly summarized,and the current problems of hollow mesoporous silica in clinical applications are analyzed.

参考文献/References:

[1] Wilczewska A Z,Niemirowicz K,Markiewicz K H,et al.Nanoparticles as drug delivery systems[J].Pharmacological Reports,2012,64(5):1020-1037.
[2] Feng Yin,Panwar N,Tng D J H,et al.The application of mesoporous silica nanoparticle family in cancer theranostics[J].Coordination Chemistry Reviews,2016,319:86-109.
[3] Kresge C T,Leonowicz M E,Roth W J,et al.Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism[J].Nature,1992,359(6397):710-712.
[4] Tang Fangqiong,Li Linlin,Chen Dong.Mesoporous silica nanoparticles:synthesis,biocompatibility and drug delivery[J].Advanced Materials,2012,24(12):1504-1534.
[5] Vallet-Regi M,Ramila A,Del Real R P,et al.A new property of MCM-41:drug delivery system[J].Chemistry of Materials,2001,13(2):308-311.
[6] Lai Chengyu,Trewyn B G,Jeftinija D M,et al.A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules[J].Journal of the American Chemical Society,2003,125(15):4451-4459.
[7] Dai Liangliang,Zhang Qingfeng,Shen Xinkun,et al.A pH-responsive nanocontainer based on hydrazone-bearing hollow silica nanoparticles for targeted tumor therapy[J].Journal of Materials Chemistry B,2016,4(26):4594-4604.
[8] Liu Junjie,Luo Zhong,Zhang Jixi,et al.Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy[J].Biomaterials,2016,83:51-65.
[9] Zou Zhen,Li Siqi,He Dinggeng,et al.A versatile stimulus-responsive metal-organic framework for size/morphology tunable hollow mesoporous silica and pH-triggered drug delivery[J].Journal of Materials Chemistry B,2017,5(11):2126-2132.
[10] Jia Xiaomin,Yang Zhiyuan,Wang Yujun,et al.Hollow mesoporous silica@ metal-organic framework and applications for pH-responsive drug delivery[J].Chem Med Chem,2018,13(5):400-405.
[11] Poostforooshan J,Belbekhouche S,Shaban M,et al.Aerosol-assisted synthesis of tailor-made hollow mesoporous silica microspheres for controlled release of antibacterial and anticancer agents[J].ACS Applied Materials and Interfaces,2020,12(6):6885-6898.
[12] Wibowo F R,Saputra O A,Lestari W W,et al.pH-triggered drug release controlled by poly(styrene sulfonate)growth hollow mesoporous silica nanoparticles[J].ACS Omega,2020,5(8):4261-4269.
[13] Qiu Qiaohua,Quan Zhenzhen,Zhang Hongnan,et al.pH-triggered sustained drug release of multilayer encapsulation system with hollow mesoporous silica nanoparticles/chitosan/polyacrylic acid[J].Materials Letters,2020,260:126907.
[14] Liu Xiaojia,Pan Xi,Sun Mingze,et al.Importance of robust and reliable nanochannel sealing for enhancing drug delivery efficacy of hollow mesoporous nanocontainer[J].ACS Applied Bio Materials,2020,3(3):1434-1443.
[15] Shao Mei,Chang Cong,Liu Zuhao,et al.Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance[J].Colloids and Surfaces B:Biointerfaces,2019,183:110427.
[16] Hadipour Moghaddam S P,Yazdimamaghani M,Ghandehari H.Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery[J].Journal of Controlled Release,2018,282:62-75.
[17] Zhang Yuanyuan,Qu Qiuyu,Cao Xiang,et al.NIR-absorbing dye functionalized hollow mesoporous silica nanoparticles for combined photothermal-chemotherapy[J].Chemical Communications,2017,53(88):12032-12035.
[18] Chen Zhongyin,Wan Lihui,Yuan Ye,et al.pH/GSH-dual-sensitive hollow mesoporous silica nanoparticle-based drug delivery system for targeted cancer therapy[J].ACS Biomaterials Science and Engineering,2020,6(6):3375-3387.
[19] Wang Xuemei,Ding Xin,Yu Bing,et al.Tumor microenvironment-responsive polymer with chlorin e6 to interface hollow mesoporous silica nanoparticles-loaded oxygen supply factor for boosted photodynamic therapy[J].Nanotechnology,2020,31(30):305709.
[20] Yu Yang,Duan Junchao,Li Yang,et al.Silica nanoparticles induce liver fibrosis via TGF-β1/Smad3 pathway in ICR mice[J].International Journal of Nanomedicine,2017,12:6045.
[21] Huang Ping,Chen Yu,Lin Han,et al.Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality[J].Biomaterials,2017,125:23-37.
[22] Hadipour Moghaddam S P,Yazdimamaghani M,Ghandehari H.Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery[J].Journal of Controlled Release,2018,282:62-75.
[23] Kaziem A E,Gao Yunhao,He Shun,et al.Synthesis and insecticidal activity of enzyme-triggered functionalized hollow mesoporous silica for controlled release[J].Journal of Agricultural and Food Chemistry,2017,65(36):7854-7864.
[24] Jin Zhaokui,Wen Yanyuan,Xiong Liwei,et al.Intratumoral H2O2-triggered release of CO from a metal carbonyl-based nanomedicine for efficient CO therapy[J].Chemical Communications,2017,53(40):5557-5560.
[25] Yang Xue,He Dinggeng,He Xiaoxiao,et al.Synthesis of hollow mesoporous silica nanorods with controllable aspect ratios for intracellular triggered drug release in cancer cells[J].ACS Applied Materials and Interfaces,2016,8(32):20558-20569.
[26] Hu Chi,West K R,Scherman O A.Hollow mesoporous raspberry-like colloids with removable caps as photoresponsive nanocontainers[J].Nanoscale,2016,8(15):7840-7844.
[27] Wu Si,Butt H J.Near-infrared-sensitive materials based on upconverting nanoparticles[J].Advanced Materials,2016,28(6):1208-1226.
[28] Chen Zhijun,Thiramanas R,Schwendy M,et al.Upconversion nanocarriers encapsulated with photoactivatable Ru complexes for near-infrared light-regulated enzyme activity[J].Small,2017,13(46):1700997.
[29] Hai Luo,Jia Xin,He Dinggeng,et al.DNA-functionalized hollow mesoporous silica nanoparticles with dual cargo loading for near-infrared-responsive synergistic chemo-photothermal treatment of cancer cells[J].ACS Applied Nano Materials,2018,1(7):3486-3497.
[30] Hu Wei,Bai Xiaowen,Wang Yaping,et al.Upper critical solution temperature polymer-grafted hollow mesoporous silica nanoparticles for near-infrared-irradiated drug release[J].Journal of Materials Chemistry B,2019,7(38):5789-5796.
[31] Fang Junfeng,Wang Qiu,Yang Guangji,et al.Albumin-MnO2 gated hollow mesoporous silica nanosystem for modulating tumor hypoxia and synergetic therapy of cervical carcinoma[J].Colloids and Surfaces B:Biointerfaces,2019,179:250-259.
[32] 母佳富,高银璐,孟奂,等.还原和pH双重响应型中空介孔二氧化硅递送系统的制备与评价[J].沈阳药科大学学报,2019,36(3):195-201.
[33] Jiao Jian,Li Xian,Zhang Sha,et al.Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release[J].Materials Science and Engineering:C,2016,67:26-33.
[34] Lu Lili,Xiong Wenya,Ma Junbin,et al.Design of dual-responsive nanocarries with high drug loading capacity based on hollow mesoporous organosilica nanoparticles[J].Materials Chemistry and Physics,2019,233:230-235.
[35] Chen Qi,Chen Yunna,Zhang Wenjing,et al.Acidity and glutathione dual-responsive polydopamine coated organic-inorganic hybrid hollow mesoporous silica nanoparticles for controlled drug delivery[J].Chem Med Chem,2020,15(20):1940-1946.
[36] Wu Yifan,Lu Junya,Mao Yuling,et al.Composite phospholipid-coated hollow mesoporous silica nanoplatform with multi-stimuli responsiveness for combined chemo-photothermal therapy[J].Journal of Materials Science,2020,55(12):5230-5246.
[37] Zhou Shuai,Ding Chendi,Wang Yang,et al.Supramolecular valves functionalized rattle-structured UCNPs@hm-SiO2 nanoparticles with controlled drug release triggered by quintuple stimuli and dual-modality imaging functions:a potential theranostic nanomedicine[J].ACS Biomaterials Science and Engineering,2019,5(11):6022-6035.
[38] Sindhwani S,Syed A M,Ngai J,et al.The entry of nanoparticles into solid tumours[J].Nature Materials,2020,19(5):566-575.
[39] Liu Qianqian,Xu Nan,Liu Liping,et al.Dacarbazine-loaded hollow mesoporous silica nanoparticles grafted with folic acid for enhancing antimetastatic melanoma response[J].ACS Applied Materials and Interfaces,2017,9(26):21673-21687.
[40] Ke You,Xiang Cheng.Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy[J].International Journal of Nanomedicine,2018,13:8339-8354.
[41] Dong Jingjing,Yao Xinyue,Sun Shian,et al.In vivo targeting of breast cancer with a vasculature-specific GQDs/hMSN nanoplatform[J].RSC Advances,2019,9(20):11576-11584.
[42] Xu Zhiqiang,Joshi N,Agarwal A,et al.Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest[J].Journal of Neuro-Oncology,2012,108(1):59-67.
[43] Nejabat M,Mohammadi M,Abnous K,et al.Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma[J].Carbohydrate Polymers,2018,197:157-166.
[44] Yao Xinyue,Qian Chuntong,Zhong Yuanyuan,et al.In vivo targeting of breast cancer with peptide functionalized GQDs/hMSN nanoplatform[J].Journal of Nanoparticle Research,2019,21(12):263.
[45] Zhao Qinfu,Wang Shengyu,Yang Yang,et al.Hyaluronic acid and carbon dots-gated hollow mesoporous silica for redox and enzyme-triggered targeted drug delivery and bioimaging[J].Materials Science and Engineering:C,2017,78:475-484.
[46] Huang Lin,Liu Jia,Gao Fan,et al.A dual-responsive,hyaluronic acid targeted drug delivery system based on hollow mesoporous silica nanoparticles for cancer therapy[J].Journal of Materials Chemistry B,Materials for Biology and Medicine,2018,6(28):4618-4629.
[47] Cao Yue,Wu Chao,Liu Ying,et al.Folate functionalized pH-sensitive photothermal therapy traceable hollow mesoporous silica nanoparticles as a targeted drug carrier to improve the antitumor effect of doxorubicin in the hepatoma cell line SMMC-7721[J].Drug Delivery,2020,27(1):258-268.
[48] Yan Tingsheng,He Jinmei,Liu Rongmei,et al.Chitosan capped pH-responsive hollow mesoporous silica nanoparticles for targeted chemo-photo combination therapy[J].Carbohydrate Polymers,2020,231:115706.
[49] Ding Xiao,Yu Wenjie,Wan Yunfeng,et al.A pH/ROS-responsive,tumor-targeted drug delivery system based on carboxymethyl chitin gated hollow mesoporous silica nanoparticles for anti-tumor chemotherapy[J].Carbohydrate Polymers,2020,245:116493.
[50] Caltagigone C,Bettoschi A,Garau A,et al.Silica-based nanoparticles:a versatile tool for the development of efficient imaging agents[J].Chemical Society Reviews,2015,44(14):4645-4671.
[51] Meng Xianfu,Zhang Hua,Zhang Meng,et al.Negative CT contrast agents for the diagnosis of malignant osteosarcoma[J].Advanced Science,2019,6(23):1901214.
[52] You Yongqiang,Huang Kaiwei,Liu Xiaojia,et al.Hydrophilic ultralong organic nanophosphors[J].Small,2020,16(8):1906733.
[53] Lu Nan,Fan Wenpei,Yi Xuan,et al.Biodegradable hollow mesoporous organosilica nanotheranostics for mild hyperthermia-induced bubble-enhanced oxygen-sensitized radiotherapy[J].ACS Nano,2018,12(2):1580-1591.
[54] Goel S,Ferreira C A,Chen Feng,et al.Activatable hybrid nanotheranostics for tetramodal imaging and synergistic photothermal/photodynamic therapy[J].Advanced Materials,2018,30(6):1704367.
[55] Zhang Xing,Ong Achwa Machuki J,Pan Wenzhen,et al.Carbon nitride hollow theranostic nanoregulators executing laser-activatable water splitting for enhanced ultrasound/fluorescence imaging and cooperative phototherapy[J].ACS Nano,2020,14(4):4045-4060.

备注/Memo

备注/Memo:
收稿日期:2020-10-14
基金项目:国家“重大新药创制”科技重大专项(2018ZX09721002-008)和江西省教育厅成果落地重点课题(GJJ10006)资助项目.
通信作者:蔡险峰(1968-),男,浙江温州人,副教授,主要从事壳聚糖药用辅料的开发与利用研究.E-mail:jccxf68@126.com
更新日期/Last Update: 2021-04-10